Twice-Yearly Injection Shows Promise For High Blood Pressure Treatment In Global Trial
A global phase 2 trial found twice-yearly zilebesiran injections significantly reduce systolic blood pressure in high blood pressure patients.
Read MoreALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A global phase 2 trial found twice-yearly zilebesiran injections significantly reduce systolic blood pressure in high blood pressure patients.
Read More